Drug Maker Pays $360 Million to Settle Investigation Into Charity Kickbacks

Photo of Drug Maker Pays $360 Million to Settle Investigation Into Charity Kickbacks
Facebook
VKontakte
share_fav

Prosecutors accused Actelion Pharmaceuticals, which Johnson & Johnson acquired in 2017, of violating Medicare laws by funneling money through a patient-assistance charity.

view The New York Times: Science
#johnson johnson
#bribery and kickbacks
#actelion pharmaceuticals ltd
#drugs pharmaceuticals
#prices fares fees and rates
#medicare
#pulmonary hypertension
#justice department
#health insurance and managed care
#united therapeutics corporation